Cardiac autonomic neuropathy in type 1 and type 2 diabetes patients

Cardiac autonomic neuropathy in type 1 and type 2 diabetes patients

Abstract Background Cardiac autonomic neuropathy (CAN) in diabetes is among the strongest risk markers for future global and cardiovascular mortality. The aim of this study was to analyse CAN prevalence and to compare the associations between CAN, the glycaemic control, cardiovascular risk factors,...

Full description

Bibliographic Details
Main Authors: Anca Moţăţăianu, Smaranda Maier, Zoltan Bajko, Septimiu Voidazan, Rodica Bălaşa, Adina Stoian
Format: Article
Language:English
Published: BMC 2018-08-01
Series:BMC Neurology
Subjects:
Cardiac autonomic neuropathy
Type 1 diabetes
Type 2 diabetes
Microvascular complication
Macrovascular complication
Cardiovascular risk factors
Online Access:http://link.springer.com/article/10.1186/s12883-018-1125-1

Internet

http://link.springer.com/article/10.1186/s12883-018-1125-1

Similar Items